ArticleTherapeutic advances in musculoskeletal disease2026
Associations of blood cell indices with the severity of rheumatoid arthritis: a retrospective case-control and machine learning modeling study.
Article in Therapeutic advances in musculoskeletal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immune cells are involved in rheumatoid arthritis (RA), but the link between other blood cell indices and the disease activity of RA, along with the underlying mechanisms, is unclear. Objective: This study aimed to develop an interpretable machine learning model based on blood cell parameters to assess RA disease severity and assist in personalized treatment decisions. Methods: A retrospective case-control study was conducted with blood routine and biochemical detection data from 4401 patients at the First Affiliated Hospital of Guangxi Medical University, spanning from January 1, 2018, to January 1, 2024. The primary outcome was disease severity stratification. Recursive feature elimination was applied to identify key variables, and 10 machine learning algorithms were benchmarked on 55 clinical features with internal validation. Model interpretability was assessed with SHAP, while logistic regression and restricted cubic spline models were used to examine associations between blood cell indices and disease severity. In addition, Mendelian randomization analysis was performed to explore potential causal relationships. Design: This was a retrospective case-control study. Results: Blood cell indices were identified as the primary factors associated with RA severity. In model evaluation, the Random Forest achieved the best performance, with test set AUCs of 0.870 and 0.874. Mendelian randomization supported a causal relationship between blood cell indices and RA risk. Conclusion: These results reinforce the associations between blood cell indices and RA severity. The machine learning model demonstrates good predictive capabilities for RA severity and may assist clinicians in developing personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.